Ledger.Open graph →
SEC Form D · filed October 21, 2021

Trevi Therapeutics, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Dominick L. Colangelo · New Haven, CTDirectorEdward L. Mathers · New Haven, CTDirectorThomas L. Sciascia · New Haven, CTExecMichael L. Heffernan · New Haven, CTDirectorAnne L. Vanlent · New Haven, CTDirectorDavid L. Meeker · New Haven, CTDirectorWilliam L. Forbes · New Haven, CTExecLisa L. Delfini · New Haven, CTExecJennifer L. Good · New Haven, CTExec · DirectorJames L. Cassella · New Haven, CTDirectorBrian Mcloughlin · San Francisco, CAExecAnurag Kanungo · San Francisco, CADirectorAbali Hoilett · Grand Cayman, Cayman IslandsDirectorAlastair Riddell · BOCA RATON, FLExecJames Sapirstein · BOCA RATON, FLDirectorCharles Casamento · BOCA RATON, FLDirectorSarah Romano · BOCA RATON, FLDirectorEdward Borkowski · BOCA RATON, FLDirectorTanya Campbell · Grand Cayman, Cayman IslandsExec · DirectorAidan Madigan-Curtis · San Francisco, CAExecChi E. Zhang · Central, Hong Kong, IsraelDirectorGordon H. Ip · Richardson, TXDirectorSteven P. Belcher · New York, NYExecBradley J. Shisler · Dallas, TXDirectorRyan E. Schedler · Dallas, TXDirectorHerve Francois · New Hope, PAExec · DirectorJustin Fraser · New Hope, PADirectorMatthew Faircloth · New Hope, PAExecCraig S. Hughes · Austin, TXExecSteve S. Oden, Jr · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗